Intellectual Property Advisory Market Operations & Deployment Crisis Resolution
Davistrate Brand Strategy (Greater China) Limited, Hong Kong
Delivering end-to-end multi-jurisdictional filing management to ensure strict alignment with local statutory and quality standards. We bridge international corporate operations with regional regulatory mandates, safeguarding product legitimacy while accelerating time-to-market.
Delivering strategic regulatory intelligence and hands-on filing management to ensure strict compliance with NMPA, FDA, and global standards—reducing time-to-market while safeguarding product credibility
Assisting enterprise clients in securing regulatory approvals and product certifications in new target markets. This includes managing end-to-end NMPA compliance filings in China across regulated sectors such as cosmetics, food products, medical devices, health supplements, and pharmaceuticals.
Assisting enterprise clients in building in-country sales and marketing teams or securing master distributor partners to establish integrated online and offline (O2O) commercial models across new target jurisdictions.
Facilitating compliant engagement with local regulatory authorities in new target markets while delivering comprehensive tax and policy advisory support.
We deliver empirical benchmarking analysis across key industry leaders, evaluating competitors' IP portfolios, regulatory compliance frameworks, and go-to-market strategies. By identifying competitive gaps and regulatory precedents, we empower clients to de-risk market expansion, optimize IP protection, and capture market share with high-precision strategic positioning.
We navigate highly complex cross-border regulatory environments, orchestrating multi-jurisdictional compliance frameworks across major global markets. From pre-market technical dossier preparation and laboratory testing verification to official agency filings—such as China NMPA, US FDA, and EU CE—we streamline authorization pathways, mitigate non-compliance risks, and accelerate international market entry.
Full-scope regulatory filing and approval services for regulated product categories, including cosmetics, food products, medical devices, health supplements, and pharmaceuticals.
Assisting enterprise clients in building in-country sales and marketing teams, or identifying master distributor partners to establish integrated online and offline (O2O) business models in new target jurisdictions.
Executing deep-dive background vetting and forensic audits to identify hidden conflicts of interest, grey-market diversion, and integrity breaches within key agency networks—protecting principal brands from operational and reputational exposures.
Engineering strategic agency contracts designed to balance aggressive sales targets with uncompromised brand protection. We establish enforceable compliance KPIs, zero-tolerance provisions for unauthorized sub-licensing or grey-market diversion, and seamless exit strategies to safeguard principal interests.
Executing swift, multi-pronged enforcement actions against rogue distributors to regain control over supply chains and brand IP. We secure emergency legal remedies, conduct inventory seizures, and shut down unauthorized distribution channels before commercial losses escalate.
Assisting enterprise clients in securing regulatory approvals and product certifications in new target jurisdictions. This includes managing end-to-end NMPA compliance filings in China across regulated sectors such as cosmetics, food products, medical devices, health supplements, and pharmaceuticals.
